NASDAQ: IRIXIridex Corp Stock Ownership - Who owns Iridex?
Insider buying vs selling
Have Iridex Corp insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Nandini Devi | Director | 2023-06-14 | 39,267 | $1.91 | $75.00kBuy |
| Robert Earle Grove | Director | 2023-06-14 | 39,267 | $1.91 | $75.00kBuy |
| Beverly A. Huss | Director | 2023-06-14 | 39,267 | $1.91 | $75.00kBuy |
| Ken Ludlum | Director | 2023-06-14 | 39,267 | $1.91 | $75.00kBuy |
| Scott Shuda | Director | 2023-06-14 | 39,267 | $1.91 | $75.00kBuy |
IRIX insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when IRIX insiders and whales buy or sell their stock.
IRIX Shareholders
What type of owners hold Iridex Corp stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Blueline Catalyst Fund Ix LP | 15.75% | 2,559,122 | $7.52M | Insider |
| Blueline Capital Partners Ii LP | 15.43% | 2,508,100 | $7.37M | Insider |
| Blueline Partners LLC 1 | 15.28% | 2,483,815 | $7.30M | Insider |
| Blueline Partners LLC | 15.17% | 2,465,222 | $7.25M | Insider |
| Scott Shuda | 10.64% | 1,728,602 | $5.08M | Insider |
| Topcon America Corp | 9.96% | 1,618,122 | $4.76M | Insider |
| Associates Paragon Associates Ii Joint Venture Paragon | 8.12% | 1,320,000 | $3.88M | Insider |
| Acuta Capital Fund LP | 7.12% | 1,157,011 | $3.40M | Insider |
| Blueline Capital Partners LP | 7.01% | 1,138,862 | $3.35M | Insider |
| Paragon Associates Paragon Associates Ii Joint Venture | 6.15% | 1,000,000 | $2.94M | Institution |
IRIX vs Medical Device Stocks
Iridex Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.